Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France.
Ain Shams University, Cairo, Egypt.
Lancet Glob Health. 2014 Sep;2(9):e541-e549. doi: 10.1016/S2214-109X(14)70188-3. Epub 2014 Aug 27.
Most hepatitis C virus (HCV) transmission in Egypt is related to medical injections and procedures. To control the spread of HCV, the Egyptian Ministry of Health initiated awareness and education campaigns, strengthened infection control in health-care facilities, and subsidised anti-HCV treatment. We aimed to investigate the effect of these interventions on the spread of HCV by mathematical modelling.
We developed a mathematical model of HCV transmission in Zawyat Razin, a typical rural community. Our model assumes that each individual has two distinct types of medical procedures: injections and more invasive medical procedures. To quantify the severity of the spread of HCV, we used the notion of the basic reproduction number R0, a standard threshold parameter signalling whether transmission of an infectious disease is self-sustained and maintains an epidemic. If R0 is greater than 1, HCV is self-sustained; if R0 is 1 or less, HCV transmission is not self-sustained. We investigated whether heterogeneity in the rate of injection or invasive medical procedures is the determinant factor for HCV transmission and whether most iatrogenic transmission is caused by a small group of individuals who receive health-care interventions frequently. We then assessed whether interventions targeted at this group could reduce the spread of HCV.
The R0 of the spread of HCV without treatment was 3·54 (95% CI 1·28-6·18), suggesting a self-sustained spread. Furthermore, the present national treatment programme only decreased R0 from 3·54 to 3·03 (95% CI 1·10-5·25). Individuals with high rates of medical injections seem to be responsible for the spread of HCV in Egypt; the R0 of the spread of HCV without treatment would be 0·64 (95% CI 0·41-0·93) if everybody followed the average behaviour. The effect of treatment on HCV transmission is greatly enhanced if treatment is provided a mean of 2·5 years (95% CI 0·1-9·2) after chronic infection and with drug regimens with more than 80% efficacy. With these treatment parameters, preventive and curative interventions targeting individuals with high rates of medical injections might decrease R0 below 1 for treatment coverage lower than 5%.
Targeting preventive and curative interventions to individuals with high rates of medical injections in Egypt would result in a greater reduction the spread of HCV than would untargeted allocation. Such an approach might prove beneficial in other resource-limited countries with health-care-driven epidemics.
Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS 1211), ANR grant Labex Integrative Biology of Emerging Infectious Diseases.
埃及大多数丙型肝炎病毒(HCV)传播与医疗注射和程序有关。为了控制 HCV 的传播,埃及卫生部发起了意识和教育活动,加强了医疗机构的感染控制,并补贴了抗 HCV 治疗。我们旨在通过数学建模研究这些干预措施对 HCV 传播的影响。
我们在 Razin 农村社区开发了 HCV 传播的数学模型。我们的模型假设每个人都有两种不同类型的医疗程序:注射和更具侵入性的医疗程序。为了量化 HCV 传播的严重程度,我们使用了基本繁殖数 R0 的概念,这是一个表示传染病传播是否自我维持和维持流行的标准阈值参数。如果 R0 大于 1,则 HCV 是自我维持的;如果 R0 为 1 或更低,则 HCV 传播不是自我维持的。我们研究了注射或侵入性医疗程序的速度异质性是否是 HCV 传播的决定因素,以及大多数医源性传播是否是由经常接受医疗干预的一小部分个体引起的。然后,我们评估了针对该群体的干预措施是否可以减少 HCV 的传播。
未经治疗的 HCV 传播的 R0 为 3.54(95%CI 1.28-6.18),表明存在自我维持的传播。此外,目前的国家治疗计划仅将 R0 从 3.54 降低到 3.03(95%CI 1.10-5.25)。具有高医疗注射率的个体似乎对埃及 HCV 的传播负有责任;如果每个人都遵循平均行为,未经治疗的 HCV 传播的 R0 将为 0.64(95%CI 0.41-0.93)。如果在慢性感染后平均 2.5 年(95%CI 0.1-9.2)并使用超过 80%疗效的药物方案提供治疗,治疗对 HCV 传播的影响将大大增强。在这些治疗参数下,针对医疗注射率较高的个体的预防和治疗干预措施可能会使 R0 低于 1,而治疗覆盖率低于 5%。
针对埃及高医疗注射率的个体进行预防和治疗干预,将比无针对性分配更能减少 HCV 的传播。这种方法可能对其他具有医疗驱动的传染病的资源有限的国家有益。
法国艾滋病和病毒性肝炎研究机构(ANRS)1211、法国国家研究署实验室综合新兴传染病生物学。